Does BAMLANIVIMAB Cause Interstitial lung disease? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Interstitial lung disease have been filed in association with BAMLANIVIMAB. This represents 0.2% of all adverse event reports for BAMLANIVIMAB.
8
Reports of Interstitial lung disease with BAMLANIVIMAB
0.2%
of all BAMLANIVIMAB reports
0
Deaths
8
Hospitalizations
How Dangerous Is Interstitial lung disease From BAMLANIVIMAB?
Of the 8 reports, 8 (100.0%) required hospitalization, and 3 (37.5%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BAMLANIVIMAB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does BAMLANIVIMAB Cause?
Dyspnoea (833)
Infusion related reaction (663)
Pyrexia (641)
Chills (453)
Oxygen saturation decreased (448)
Nausea (422)
Covid-19 (346)
Cough (342)
Covid-19 pneumonia (313)
Hypoxia (310)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which BAMLANIVIMAB Alternatives Have Lower Interstitial lung disease Risk?
BAMLANIVIMAB vs BAMLANIVIMAB\ETESEVIMAB
BAMLANIVIMAB vs BARACLUDE
BAMLANIVIMAB vs BARICITINIB
BAMLANIVIMAB vs BARIUM
BAMLANIVIMAB vs BARNIDIPINE